Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioVie Inc

1.08
+0.06005.88%
Post-market: 1.080.00000.00%19:51 EDT
Volume:155.53K
Turnover:165.69K
Market Cap:19.93M
PE:-0.35
High:1.10
Open:1.04
Low:1.03
Close:1.02
Loading ...

New to The Street Show 633 to Broadcast on Fox Business Network as Sponsored Programming Tonight at 10:30 PM PST Featuring Zapp Electric Vehicles ($ZAPP), BioVie ($BIVI), PetVivo ($PETV), and Banzai ($BNZI)

ACCESS Newswire
·
10 Mar

New to the Street Airs Show #630 on Fox Business Network Tonight at 10:30 PM PST Featuring Roadzen ($RDZN), BioVie ($BIVI), AtlasClear (ATCH), eXoZymes ($EXOZ), and EvolveHealthandLifestyle.com With Craig Bruce

ACCESS Newswire
·
04 Mar

New to The Street to Broadcast Live on Bloomberg Tonight at 6:30 PM EST as Sponsored Programming, Spotlighting BioVie (BIVI), RoadZen (RDZN), HPB, and Sustainable Innovation With Shark Tank’s Kevin Harrington and Sustainable Green Team (SGTM)

ACCESS Newswire
·
23 Feb

Is BioVie (NASDAQ:BIVI) In A Good Position To Invest In Growth?

Simply Wall St.
·
13 Feb

BioVie files to sell 7.71M shares of common stock for holders

seekingalpha
·
22 Nov 2024

BioVie to Present Design of Planned Phase 2 Study of Bezisterim for the Treatment of Long COVID at the Demystifying Long COVID International Conference

GlobeNewswire
·
20 Nov 2024

BioVie says Parkinson’s Disease clinical trial is fully funded

TIPRANKS
·
04 Nov 2024

BioVie Inc - Raises Over $15 Million From Secondary Offerings

THOMSON REUTERS
·
04 Nov 2024

BioVie Inc - Pd-202 Trial Expected to Start Early 2025, Results by Late 2025

THOMSON REUTERS
·
04 Nov 2024

BioVie’s Upcoming Parkinson’s Disease Clinical Trial Is Fully Funded

THOMSON REUTERS
·
04 Nov 2024

BioVie’s Upcoming Parkinson’s Disease Clinical Trial is Fully Funded

GlobeNewswire
·
04 Nov 2024

BioVie Inc. Announces Closing of Registered Direct Offering

THOMSON REUTERS
·
30 Oct 2024

BioVie Inc. Announces Closing of Registered Direct Offering

GlobeNewswire
·
30 Oct 2024

BRIEF-BioVie Announces Pricing Of Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Reuters
·
29 Oct 2024

Update -- BioVie Inc. Announces Pricing of Registered Direct Offering Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
29 Oct 2024

BioVie 1.15M share registered direct offering priced at $2.83

TIPRANKS
·
29 Oct 2024